"Repurposing of FDA-approved drugs as potential inhibitors of the ..."

Abhik Kumar Ray et al. (2022)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOMED.2021.105183

access: closed

type: Journal Article

metadata version: 2025-05-31

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cbm/RayGPBBR22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/RayGPBBR22
Abhik Kumar Ray, Parth Sarthi Sen Gupta, Saroj Kumar Panda, Satyaranjan Biswal, Uddipan Bhattacharya, Malay Kumar Rana:
Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. Comput. Biol. Medicine 142: 105183 (2022)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.